Recombinant Anti-CTLA4 x Anti-GLUT2 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CTLA4 and anti-GLUT2 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two factors simultaneously. It is designed for the research of Renal cell cancer (RCC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CTLA4 x Anti-GLUT2 Bispecific Antibody (scIgG) (SCIGG-145). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS